REGENXBIO director Kenneth T. Mills resigns effective Oct 21; George Migausky named Chairman

REGENXBIO Inc.

Kenneth T. Mills resigned from REGENXBIO's board on October 14, 2026, effective October 21, 2026, after becoming chief executive officer of another company.
The company said Mills' decision was not related to any disagreement with REGENXBIO on matters of operations, policies, or practices.
The board appointed George Migausky as Chairman of the Board in connection with Mills' departure.
Daniel Tassé stepped down as Lead Independent Director because the new Chairman is an independent director, but remains a member of the board.
Filing signed October 16, 2026 by Patrick J. Christmas II, Executive Vice President, Chief Strategy & Legal Officer.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.